Granules Stock Screener | Share Price & Fundamental Analysis
GRANULES
Pharmaceuticals
Share Price NSE
₹638.80
▼
-5.20 (-0.81%)
Share Price BSE
₹638.75
▼
-5.05 (-0.78%)
Track Granules share price live with TickJournal's free stock screener.
Analyze Granules share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Granules Market Cap
₹15,204.80 Cr.
GRANULES P/E Ratio (TTM)
27.31
Granules P/B Ratio
3.74
EPS (TTM)
₹20.69
Dividend Yield
0.24%
Debt to Equity
0.40
GRANULES 52 Week High
₹644.00
Granules 52 Week Low
₹431.10
Operating Margin
21.00%
Profit Margin
12.36%
GRANULES Revenue (TTM)
₹1,230.00
EBITDA
₹284.00
Net Income
₹152.00
Total Assets
₹6,253.00
Total Equity
₹3,716.00
Granules Share Price History - Stock Screener Chart
Screen GRANULES historical share price movements with interactive charts. Analyze price trends and patterns.
Granules Company Profile - Fundamental Screener
Screen Granules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GRANULES shares.
Granules India Limited is a vertically integrated pharmaceutical company founded in 1991. It manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company specializes in off-patent drugs and first-line defense products like Paracetamol, Ibuprofen, Metformin, and Guaifenesin. Granules India operates seven manufacturing facilities, six in...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
C Krishna Prasad
ISIN
INE101D01020
Website
https://www.granulesindia.com
Granules Balance Sheet Screener
Screen GRANULES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6,253 | 5,521 | 4,905 | 4,513 | 3,714 | 3,228 | 2,983 | 2,677 | 1,879 | 1,563 |
| Current Assets | 3,116 | 2,905 | 2,574 | 2,505 | 1,997 | 1,629 | 1,282 | 1,187 | 828 | 818 |
| Fixed Assets | 2,427 | 2,096 | 1,911 | 1,541 | 1,332 | 1,204 | 944 | 777 | 644 | 560 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 534 | 213 | 256 | 284 | 367 | 491 | 557 | 495 | 188 | 247 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3,716 | 3,226 | 2,835 | 2,587 | 2,173 | 1,844 | 1,530 | 1,304 | 904 | 662 |
| Share Capital | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 23 | 22 |
| Reserves & Surplus | 3,691 | 3,201 | 2,811 | 2,562 | 2,149 | 1,818 | 1,504 | 1,279 | 881 | 613 |
Granules Income Statement Screener - Profit & Revenue Analysis
Screen Granules income statement and profit fundamentals.
Analyze GRANULES quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Granules share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,230 | 1,225 | 1,294 | 1,374 | 1,171 | 1,171 | 960 | 1,139 | 1,199 | 984 | 1,190 | 1,150 | 1,034 | 1,024 | 1,156 |
| Expenses | 945 | 989 | 1,019 | 1,080 | 920 | 921 | 763 | 907 | 967 | 849 | 977 | 905 | 837 | 808 | 908 |
| EBITDA | 284 | 236 | 275 | 295 | 251 | 251 | 197 | 232 | 232 | 135 | 213 | 245 | 197 | 216 | 248 |
| Operating Profit % | 21.00% | 18.00% | 21.00% | 22.00% | 21.00% | 21.00% | 20.00% | 20.00% | 19.00% | 14.00% | 18.00% | 21.00% | 19.00% | 21.00% | 21.00% |
| Depreciation | 64 | 69 | 72 | 74 | 53 | 53 | 53 | 57 | 49 | 49 | 53 | 52 | 40 | 43 | 44 |
| Interest | 24 | 24 | 29 | 29 | 29 | 27 | 26 | 27 | 19 | 23 | 26 | 29 | 6 | 7 | 13 |
| Profit Before Tax | 198 | 145 | 176 | 202 | 176 | 181 | 128 | 153 | 164 | 66 | 136 | 170 | 150 | 166 | 190 |
| Tax | 46 | 32 | 45 | 52 | 46 | 47 | 31 | 35 | 44 | 18 | 34 | 45 | 39 | 38 | 45 |
| Net Profit | 152 | 113 | 131 | 150 | 130 | 135 | 97 | 118 | 120 | 48 | 102 | 126 | 111 | 128 | 145 |
| EPS | 6.27 | 4.64 | 5.38 | 6.19 | 5.35 | 5.56 | 4.01 | 4.85 | 4.94 | 1.98 | 4.22 | 5.18 | 4.48 | 5.14 | 5.85 |
Granules Cash Flow Screener - Liquidity Fundamentals
Screen GRANULES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 867 | 439 | 739 | 332 | 433 | 476 | 262 | -1 | 188 | 151 |
| Investing Activities | -689 | -358 | -192 | -379 | -277 | -160 | -270 | -462 | -326 | -162 |
| Financing Activities | -93 | 8 | -440 | 190 | -299 | -213 | -17 | 529 | 56 | 86 |
| Net Cash Flow | 85 | 90 | 107 | 143 | -144 | 103 | -25 | 66 | -82 | 75 |
Granules Shareholding Pattern Screener
See Granules shareholding pattern with promoter, FII, and DII holdings.
Check Granules promoter holding and ownership changes for GRANULES on TickJournal.
| Item | 2026-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 38.02% | 38.84% | 38.82% | 38.82% | 38.82% | 41.96% | 38.87% | 38.87% |
| FII Holding | 13.79% | 15.15% | 0.00% | 14.09% | 13.55% | 19.57% | 20.39% | 19.49% |
| DII Holding | 18.51% | 22.45% | 22.74% | 17.92% | 17.48% | 10.70% | 14.12% | 14.86% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.31% | 16.07% | 16.54% | 18.28% | 19.19% | 19.38% | 18.78% | 18.29% |
| Other Holding | 10.38% | 7.50% | 21.89% | 10.89% | 10.96% | 8.39% | 7.84% | 8.49% |
| Shareholder Count | 163,818 | 169,802 | 169,700 | 165,542 | 163,184 | 182,142 | 179,870 | 202,198 |
Granules Share Dividend Screener - Share Yield Analysis
Check Granules dividend history with payout and yield data.
View Granules dividend details including ex-dates and amounts for GRANULES stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 0.24% |
| 2024-March | ₹1.50 | 0.31% |
| 2023-March | ₹1.50 | 0.35% |
| 2022-March | ₹1.50 | 0.52% |
| 2021-March | ₹1.50 | 0.49% |
| 2020-March | ₹1.00 | 0.33% |
| 2019-March | ₹1.00 | 0.70% |
| 2018-March | ₹1.00 | 0.87% |
| 2017-March | ₹0.90 | 0.87% |
Granules Stock Index Membership
See which indices include Granules stock.
Check GRANULES index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY HEALTHCARE
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Granules Market Events Screener - Corporate Actions
Get Granules corporate actions including splits, bonuses, and buybacks.
Check Granules stock events that may affect GRANULES share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -6.49% |
| 2026-01-22 | 2026-01-22 | Extraordinary General Meeting | NA | -10.66% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.09% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.97% |
| 2025-08-07 | 2025-08-07 | Annual General Meeting | NA | -16.92% |
| 2025-07-31 | 2025-07-31 | Dividend | ₹ 1.50 /share | -6.98% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 18.01% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -2.83% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -9.57% |
| 2024-08-06 | 2024-08-06 | Annual General Meeting | NA | 60.49% |
| 2024-07-30 | 2024-07-30 | Dividend | ₹ 1.50 /share | 41.30% |
| 2023-08-03 | 2023-08-03 | Dividend | ₹ 1.50 /share | 8.32% |
| 2022-08-22 | Buyback | 400 | -11.32% | |
| 2022-07-19 | 2022-07-21 | Dividend | ₹ 0.75 /share | 22.87% |
| 2022-02-17 | 2022-02-18 | Dividend | ₹ 0.25 /share | -2.02% |
Granules Competitors Screener - Peer Comparison
Screen GRANULES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.12 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 62.72 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 59.42 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,955 | 22.29 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.40 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.27 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.30 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.73 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.27 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.95 | 13,458 | 3.70% | 2,216 | 42.54 |
Granules Company Announcements - News Screener
Screen GRANULES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-29 | Closure of Trading Window | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-23 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-02-06 | Updates | - |
| 2026-01-28 | Transcript For Earnings Conference Call For Q3 Of FY26 | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-23 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-01-22 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-01-22 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-01-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-13 | Corrigendum To The Notice Of Extra-Ordinary General Meeting Of The Company | - |
| 2026-01-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-08 | Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Third Quarter And Nine Months Ended On December 31 2025. | - |
| 2026-01-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-02 | News Paper Publication | - |